The research time span covered by the report is from 2019 to 2030; it provides an overview of the Global Engineered T Cells Market and also provides a deeper in-depth segmentation of the market by regions, product type and downstream industries.
The global Engineered T Cells market size in 2023 is 26871.2 million US dollars, and it is expected to be 197394.2 million US dollars by 2030, with a compound annual growth rate of 33.0% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Engineered T Cells market include Amgen Inc, Bellicum Pharmaceuticals Inc., Bristol-Myers Squibb, Precision Biosciences Inc., and Eli Lilly And Company. The share of the top 3 players in the Engineered T Cells market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Engineered T Cells market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Chimeric Antigen Receptor (CAR) Modified T Cells accounted for XX% of Engineered T Cells market in 2023. T Cells Receptor (TCR) Modified T Cells share of XX%.
Lung Cancer accounted for XX% of the Engineered T Cells market in 2023. Colorectal Cancer accounts for XX%.
For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.
As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.
Key Factors Considered:
COVID-19
The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.
Regional Conflict / Russia-Ukraine War
The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it”s going to evolve in the years to come.
Challenges & Opportunities
Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapters 2-4: Segmented the global Engineered T Cells market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Engineered T Cells market country revenue data, and includes PEST Analysis.
Chapter 10: Analysis of the competitive environment of Engineered T Cells market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and new entrants and expansion plans.
Chapter 11: Analyzes the main companies in the Engineered T Cells industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapters 12-14: Provide detailed Engineered T Cells market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 15: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Player list
Amgen Inc
Bellicum Pharmaceuticals Inc.
Bristol-Myers Squibb
Precision Biosciences Inc.
Eli Lilly And Company
Gilead Sciences, Inc.
Novartis Ag
AthenexInc
Oxford BiomedicaPlc
Pfizer Inc.
Types list
Chimeric Antigen Receptor (CAR) Modified T Cells
T Cells Receptor (TCR) Modified T Cells
Tumor Infiltrating Lymphocytes
Application list
Lung Cancer
Colorectal Cancer
Melanoma
Breast Cancer
Leukemia
List of Tables and Figures
Figure Engineered T Cells Picture
Table Product Definition of Engineered T Cells
Table Economic Analysis of Global Regions
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Engineered T Cells Market Size by Type (2019 VS 2024 VS 2030)
Table Global Engineered T Cells Revenue by Type (2019-2024)
Table Global Engineered T Cells Revenue and Share by Type (2019-2024)
Table Global Engineered T Cells Market Size by Application (2019 VS 2024 VS 2030)
Table Global Engineered T Cells Revenue by Application (2019-2024)
Table Global Engineered T Cells Revenue Share by Application (2019-2024)
Figure Global Engineered T Cells Revenue Market Size Growth (2019-2024)
Table Engineered T Cells Market Size by Regions: 2019 VS 2024 VS 2030
Table Engineered T Cells Revenue Market Size by Regions (2019-2024)
Table Engineered T Cells Revenue and Share by Regions (2019-2024)
Figure North America Engineered T Cells Market Size (2019-2024)
Figure Europe Engineered T Cells Market Size (2019-2024)
Figure Asia-Pacific Engineered T Cells Market Size (2019-2024)
Figure Latin America Engineered T Cells Market Size (2019-2024)
Figure Middle East & Africa Engineered T Cells Market Size (2019-2024)
Table North America Engineered T Cells Revenue by Countries (2019-2024)
Table North America Engineered T Cells Revenue and Share by Countries (2019-2024)
Table North America PEST Analysis
Figure United States Engineered T Cells Revenue and Growth (2019-2024)
Figure Canada Engineered T Cells Revenue and Growth (2019-2024)
Figure Canada Engineered T Cells Sales and Growth (2019-2024)
Table Asia-Pacific Engineered T Cells Revenue by Countries (2019-2024)
Table Asia-Pacific Engineered T Cells Revenue and Share by Countries (2019-2024)
Table Asia-Pacific PEST Analysis
Figure China Engineered T Cells Revenue and Growth (2019-2024)
Figure Japan Engineered T Cells Revenue and Growth (2019-2024)
Figure Korea Engineered T Cells Revenue and Growth (2019-2024)
Figure Southeast Asia Engineered T Cells Revenue and Growth (2019-2024)
Figure India Engineered T Cells Revenue and Growth (2019-2024)
Figure Australia Engineered T Cells Revenue and Growth (2019-2024)
Table Europe Engineered T Cells Revenue by Countries (2019-2024)
Table Europe Engineered T Cells Revenue and Share by Countries (2019-2024)
Table Europe PEST Analysis
Figure Germany Engineered T Cells Revenue and Growth (2019-2024)
Figure France Engineered T Cells Revenue and Growth (2019-2024)
Figure UK Engineered T Cells Revenue and Growth (2019-2024)
Figure Italy Engineered T Cells Revenue and Growth (2019-2024)
Figure Russia Engineered T Cells Revenue and Growth (2019-2024)
Figure Spain Engineered T Cells Revenue and Growth (2019-2024)
Figure Nordic Engineered T Cells Revenue and Growth (2019-2024)
Table Latin America Engineered T Cells Revenue by Countries (2019-2024)
Table Latin America Engineered T Cells Revenue and Share by Countries (2019-2024)
Table Latin America PEST Analysis
Figure Brazil Engineered T Cells Revenue and Growth (2019-2024)
Figure Argentina Engineered T Cells Revenue and Growth (2019-2024)
Figure Mexico Engineered T Cells Revenue and Growth (2019-2024)
Table Middle East & Africa Engineered T Cells Revenue by Countries (2019-2024)
Table Middle East & Africa Engineered T Cells Revenue and Share by Countries (2019-2024)
Table Middle East & Africa PEST Analysis
Figure Egypt Engineered T Cells Revenue and Growth (2019-2024)
Figure South Africa Engineered T Cells Revenue and Growth (2019-2024)
Figure UAE Engineered T Cells Revenue and Growth (2019-2024)
Figure Turkey Engineered T Cells Revenue and Growth (2019-2024)
Figure Saudi Arabia Engineered T Cells Revenue and Growth (2019-2024)
Table Global Engineered T Cells Revenue by Players (2019-2024)
Table Global Engineered T Cells Revenue Market Share by Players (2019-2024)
Figure Global Top 3 Companies Revenue Share in 2023
Figure Global Top 6 Companies Revenue Share in 2023
Table Global Engineered T Cells Players Market Concentration Ratio (CR5) (2019-2024)
Table Engineered T Cells Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table Amgen Inc Profile
Table Product Overview
Table Amgen Inc Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
Figure Amgen Inc Revenue and Growth Rate
Figure Amgen Inc Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Bellicum Pharmaceuticals Inc. Profile
Table Product Overview
Table Bellicum Pharmaceuticals Inc. Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
Figure Bellicum Pharmaceuticals Inc. Revenue and Growth Rate
Figure Bellicum Pharmaceuticals Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Bristol-Myers Squibb Profile
Table Product Overview
Table Bristol-Myers Squibb Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
Figure Bristol-Myers Squibb Revenue and Growth Rate
Figure Bristol-Myers Squibb Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Precision Biosciences Inc. Profile
Table Product Overview
Table Precision Biosciences Inc. Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
Figure Precision Biosciences Inc. Revenue and Growth Rate
Figure Precision Biosciences Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Eli Lilly And Company Profile
Table Product Overview
Table Eli Lilly And Company Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
Figure Eli Lilly And Company Revenue and Growth Rate
Figure Eli Lilly And Company Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Gilead Sciences, Inc. Profile
Table Product Overview
Table Gilead Sciences, Inc. Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
Figure Gilead Sciences, Inc. Revenue and Growth Rate
Figure Gilead Sciences, Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Novartis Ag Profile
Table Product Overview
Table Novartis Ag Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
Figure Novartis Ag Revenue and Growth Rate
Figure Novartis Ag Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table AthenexInc Profile
Table Product Overview
Table AthenexInc Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
Figure AthenexInc Revenue and Growth Rate
Figure AthenexInc Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Oxford BiomedicaPlc Profile
Table Product Overview
Table Oxford BiomedicaPlc Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
Figure Oxford BiomedicaPlc Revenue and Growth Rate
Figure Oxford BiomedicaPlc Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Pfizer Inc. Profile
Table Product Overview
Table Pfizer Inc. Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
Figure Pfizer Inc. Revenue and Growth Rate
Figure Pfizer Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Global Engineered T Cells Revenue Forecast by Type (2024-2030)
Table Global Engineered T Cells Revenue and Share Forecast by Type (2024-2030)
Table Global Engineered T Cells Revenue by Application (2024-2030)
Table Global Engineered T Cells Revenue and Share by Application (2024-2030)
Figure Global Engineered T Cells Revenue Forecast Market Size (2024-2030)
Table Engineered T Cells Revenue Forecast by Regions (2024-2030)
Table Engineered T Cells Revenue and Share Forecast by Regions (2024-2030)
Figure North America Engineered T Cells Revenue Forecast Market Size (2024-2030)
Figure Europe Engineered T Cells Revenue Forecast Market Size (2024-2030)
Figure Asia-Pacific Engineered T Cells Revenue Forecast Market Size (2024-2030)
Figure Latin America Engineered T Cells Revenue Forecast Market Size (2024-2030)
Figure Middle East & Africa Engineered T Cells Revenue Forecast Market Size (2024-2030)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
